XOMA Co. (NASDAQ:XOMAP) Short Interest Down 68.5% in January

XOMA Co. (NASDAQ:XOMAP) was the target of a significant decline in short interest in January. As of January 30th, there was short interest totaling 627 shares, a decline of 68.5% from the January 15th total of 1,989 shares. Based on an average daily trading volume, of 737 shares, the days-to-cover ratio is presently 0.9 days. Based on an average daily trading volume, of 737 shares, the days-to-cover ratio is presently 0.9 days.

XOMA Trading Up 0.4%

Shares of NASDAQ:XOMAP opened at $26.06 on Friday. The business’s 50 day moving average price is $26.52 and its 200-day moving average price is $26.37. XOMA has a 1 year low of $24.96 and a 1 year high of $30.00.

About XOMA

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.